Exjade and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exjade (deferasirox) and Fenofibrate (fenofibrate). Common drug interactions include asthenia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Exjade and Fenofibrate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Exjade?

Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

On Aug, 08, 2026

12 people who take Exjade and Fenofibrate together, and have interactions are studied.

Exjade and Fenofibrate drug interactions.

What are the common drug interactions of Exjade and Fenofibrate, by gender? *:

female:

Asthenia (weakness)
Pain
Pain in extremity
Dehydration (dryness resulting from the removal of water)
Dizziness
Fatigue (feeling of tiredness)
Wheezing (a high-pitched whistling sound made while you breath)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cough

male:

Anaemia (lack of blood)
Arthropathy
Drug ineffective
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Renal impairment (severely reduced kidney function)
Thrombocytopenia (decrease of platelets in blood)
Thrombosis mesenteric vessel (blood clot in mesenteric vein)
Tooth disorder (tooth disease)
Vertigo

What are the common drug interactions of Exjade and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Asthenia (weakness)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cough
Death
Dehydration (dryness resulting from the removal of water)
Dizziness
Fatigue (feeling of tiredness)
Gait disturbance
Haematocrit decreased

40-49:

n/a

50-59:

n/a

60+:

Anaemia (lack of blood)
Renal impairment (severely reduced kidney function)
Cardiac arrest
Cardiac murmur (an heart sound in valve abnormality)
Chills (felling of cold)
Coagulopathy (blood's ability to clot is impaired)
Dehydration (dryness resulting from the removal of water)
Depressed level of consciousness
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 25.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 8.33%
Muscle Aches (muscle pain): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 8.33%
Iron Metabolism Disorder: 1 person, 8.33%
Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 1 person, 8.33%
Dizziness: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Exjade and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously